Trial Profile
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms IMAGINE 7
- Sponsors Eli Lilly and Company
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 06 Jun 2015 Results presented at the American Diabetes Association's (ADA) 75th Scientific Sessions, according to an Eli Lilly media release.
- 06 Jun 2015 Results published in an Eli Lilly media release.